You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德斯控股(08437.HK)擬1165.7萬港元出售一間合營51%股權
格隆匯 04-22 22:17

格隆匯4月22日丨德斯控股(08437.HK)公吿,於2022年4月22日,買方皮膚醫學有限公司與賣方德斯(香港)控股有限公司(公司的直接全資附屬公司)訂立買賣協議,據此,買方有條件同意向賣方收購而賣方有條件同意向買方出售╱轉讓皇仁醫療有限公司51%股份及股東貸款,總代價為1165.7萬港元。

於公吿日期,合營公司皇仁醫療有限公司被確認為集團的合營公司,而其財務業績、資產及負債尚未綜合計入集團賬目,於完成後,集團將不再直接或間接於合營公司集團持有任何權益。

集團為獲新加坡衞生部正式認可的新加坡領先皮膚及外科專科診所,透過一系列先進完善的醫療、外科、激光及美容療程,針對影響皮膚、頭髮及指甲的各種皮膚問題提供既方便又全面的優質專業護理服務。

由於合營公司集團於註冊成立日期(即2019年12月30日)至2020年12月31日期間及截至2021年12月31日止12個月因全球政治、經濟緊張局勢以及新型冠狀病毒("COVID-19")爆發合共錄得除税後虧損淨額約26百萬港元,預期出售事項將提升本集團的財務狀況及流動性。

通過出售事項,集團的財務成本將大幅減少。由於於2021年12月31日集團於合營公司的投資並無賬面值,預期出售事項對集團營運的影響微乎其微。於出售事項後,本集團的流動性及財務狀況均將改善。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account